BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10702808)

  • 1. Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK mallorca.
    Zarza R; Moscardó M; Alvarez R; García J; Morey M; Pujades A; Vives-Corrons JL
    Haematologica; 2000 Mar; 85(3):227-32. PubMed ID: 10702808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial pyruvate kinase deficiency aggravates the phenotypic expression of band 3 deficiency in a family with hereditary spherocytosis.
    van Zwieten R; van Oirschot BA; Veldthuis M; Dobbe JG; Streekstra GJ; van Solinge WW; Schutgens RE; van Wijk R
    Am J Hematol; 2015 Mar; 90(3):E35-9. PubMed ID: 25388786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of congenital red cell pyruvate kinase and band 3 deficiency.
    Branca R; Costa E; Rocha S; Coelho H; Quintanilha A; Cabeda JM; Santos-Silva A; Barbot J
    Clin Lab Haematol; 2004 Aug; 26(4):297-300. PubMed ID: 15279669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population.
    Yawata Y; Kanzaki A; Yawata A; Doerfler W; Ozcan R; Eber SW
    Int J Hematol; 2000 Feb; 71(2):118-35. PubMed ID: 10745622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologically important mutations: red cell pyruvate kinase (Third update).
    Bianchi P; Zanella A
    Blood Cells Mol Dis; 2000 Feb; 26(1):47-53. PubMed ID: 10772876
    [No Abstract]   [Full Text] [Related]  

  • 6. [Molecular mechanism of hereditary spherocytosis].
    Bogusławska DM; Heger E; Sikorski AF
    Pol Merkur Lekarski; 2006 Jan; 20(115):112-6. PubMed ID: 16617750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Band 3Tambaú: a de novo mutation in the AE1 gene associated with hereditary spherocytosis. Implications for anion exchange and insertion into the red blood cell membrane.
    Lima PR; Baratti MO; Chiattone ML; Costa FF; Saad ST
    Eur J Haematol; 2005 May; 74(5):396-401. PubMed ID: 15813913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heavy transfusions and presence of an anti-protein 4.2 antibody in 4. 2(-) hereditary spherocytosis (949delG).
    Beauchamp-Nicoud A; Morle L; Lutz HU; Stammler P; Agulles O; Petermann-Khder R; Iolascon A; Perrotta S; Cynober T; Tchernia G; Delaunay J; Baudin-Creuza V
    Haematologica; 2000 Jan; 85(1):19-24. PubMed ID: 10629586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hereditary spherocytosis misdiagnosed as pyruvate kinase deficient hemolytic anemia.
    Vercellati C; Marcello AP; Fermo E; Barcellini W; Zanella A; Bianchi P
    Clin Lab; 2013; 59(3-4):421-4. PubMed ID: 23724634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary spherocytosis is associated with decreased pyruvate kinase activity due to impaired structural integrity of the red blood cell membrane.
    Andres O; Loewecke F; Morbach H; Kraus S; Einsele H; Eber S; Speer CP
    Br J Haematol; 2019 Nov; 187(3):386-395. PubMed ID: 31273765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical expression and laboratory detection of red blood cell membrane protein mutations.
    Palek J; Jarolim P
    Semin Hematol; 1993 Oct; 30(4):249-83. PubMed ID: 8266114
    [No Abstract]   [Full Text] [Related]  

  • 12. G-->T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP.
    Beutler E; Westwood B; van Zwieten R; Roos D
    Hum Mutat; 1997; 9(3):282-5. PubMed ID: 9090535
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hereditary spherocytosis: one year study of erythrocyte membrane proteins].
    Tshilolo L; Kagambega F; Sztern B; Vertongen F; Gulbis B
    Rev Med Brux; 1998 Oct; 19(5 Pt 1):417-23. PubMed ID: 9844481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the clinical spectrum and genetics of red blood cell membrane disorders.
    Gallagher PG
    Curr Hematol Rep; 2004 Mar; 3(2):85-91. PubMed ID: 14965483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red cell pyruvate kinase deficiency: molecular and clinical aspects.
    Zanella A; Fermo E; Bianchi P; Valentini G
    Br J Haematol; 2005 Jul; 130(1):11-25. PubMed ID: 15982340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology of inherited erythrocyte membrane disorders: hereditary spherocytosis and elliptocytosis.
    Iolascon A; Miraglia del Giudice E; Camaschella C
    Haematologica; 1992; 77(1):60-72. PubMed ID: 1356891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant Hereditary Spherocytosis and Pyruvate Kinase Deficiency in a Spanish Family with Chronic Hemolytic Anemia: Contribution of Laser Ektacytometry to Clinical Diagnosis.
    Vives Corrons JL; Krishnevskaya E; Montllor L; Leguizamon V; Garcia Bernal M
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From gene to disease; hereditary non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency].
    de Vooght KM; van Wijk R; Nieuwenhuis HK; Ploos van Amstel JK; Rijksen G; van Solinge WW
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1828-31. PubMed ID: 12382367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary spherocytosis (HS) due to loss of anion exchange transporter.
    Iolascon A; Miraglia del Giudice E; Perrotta S; Pinto L; Fiorelli G; Cappellini DM; Vasseur C; Bursaux E; Cutillo S
    Haematologica; 1992; 77(6):450-6. PubMed ID: 1289181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologically important mutations: band 3 and protein 4.2 variants in hereditary spherocytosis.
    Gallagher PG; Forget BG
    Blood Cells Mol Dis; 1997 Dec; 23(3):417-21. PubMed ID: 9446757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.